Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1991 Sep;65(9):4999–5006. doi: 10.1128/jvi.65.9.4999-5006.1991

Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

R M Iorio 1, R J Syddall 1, J P Sheehan 1, M A Bratt 1, R L Glickman 1, A M Riel 1
PMCID: PMC248963  PMID: 1651419

Abstract

Monoclonal antibodies (MAbs) to the hemagglutinin-neuraminidase (HN) glycoprotein of Newcastle disease virus delineate seven overlapping antigenic sites which form a continuum on the surface of the molecule. Antibodies to five of these sites neutralize viral infectivity principally by preventing attachment of the virion to cellular receptors. Through the identification of single amino acid substitutions in variants which escape neutralization by MAbs to these five antigenic sites, a neutralization map of HN was constructed, identifying several residues that contribute to the epitopes recognized by MAbs which block the attachment function of the molecule. These epitopes are defined, at least in part, by three domains on HN: residues 193 to 201; 345 to 353 (which include the only linear epitope we have identified in HN); and a C-terminal domain composed of residues 494, 513 to 521, and 569. To identify HN residues directly involved in receptor recognition, each of the variants was tested for its ability to agglutinate periodate-modified chicken erythrocytes. One variant with a single amino acid substitution at residue 193 was 2.5- to 3-fold more resistant to periodate treatment of erythrocytes than the wild-type virus, suggesting that this residue influences the binding of virus to a sialic acid-containing receptor(s) on the cell surface.

Full text

PDF
4999

Images in this article

5002Image
on p.5002

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumberg B., Giorgi C., Roux L., Raju R., Dowling P., Chollet A., Kolakofsky D. Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins. Cell. 1985 May;41(1):269–278. doi: 10.1016/0092-8674(85)90080-7. [DOI] [PubMed] [Google Scholar]
  2. Bratt M. A., Gallaher W. R. Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus. Proc Natl Acad Sci U S A. 1969 Oct;64(2):536–543. doi: 10.1073/pnas.64.2.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chou P. Y., Fasman G. D. Prediction of protein conformation. Biochemistry. 1974 Jan 15;13(2):222–245. doi: 10.1021/bi00699a002. [DOI] [PubMed] [Google Scholar]
  4. Clavell L. A., Bratt M. A. Hemolytic interaction of Newcastle disease virus and chicken erythrocytes. II. Determining factors. Appl Microbiol. 1972 Mar;23(3):461–470. doi: 10.1128/am.23.3.461-470.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eisenberg D., Wilcox W., McLachlan A. D. Hydrophobicity and amphiphilicity in protein structure. J Cell Biochem. 1986;31(1):11–17. doi: 10.1002/jcb.240310103. [DOI] [PubMed] [Google Scholar]
  6. Elango N., Coligan J. E., Jambou R. C., Venkatesan S. Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein. J Virol. 1986 Feb;57(2):481–489. doi: 10.1128/jvi.57.2.481-489.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gitelman A. K., Kaverin N. V., Kharitonenkov I. G., Rudneva I. A., Sklyanskaya E. L., Zhdanov V. M. Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J Gen Virol. 1986 Oct;67(Pt 10):2247–2251. doi: 10.1099/0022-1317-67-10-2247. [DOI] [PubMed] [Google Scholar]
  8. Gotoh B., Sakaguchi T., Nishikawa K., Inocencio N. M., Hamaguchi M., Toyoda T., Nagai Y. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus. Virology. 1988 Mar;163(1):174–182. doi: 10.1016/0042-6822(88)90244-9. [DOI] [PubMed] [Google Scholar]
  9. Hiebert S. W., Paterson R. G., Lamb R. A. Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J Virol. 1985 Apr;54(1):1–6. doi: 10.1128/jvi.54.1.1-6.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iorio R. M., Borgman J. B., Glickman R. L., Bratt M. A. Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J Gen Virol. 1986 Jul;67(Pt 7):1393–1403. doi: 10.1099/0022-1317-67-7-1393. [DOI] [PubMed] [Google Scholar]
  11. Iorio R. M., Bratt M. A. Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites. J Immunol. 1984 Oct;133(4):2215–2219. [PubMed] [Google Scholar]
  12. Iorio R. M., Bratt M. A. Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J Virol. 1983 Nov;48(2):440–450. doi: 10.1128/jvi.48.2.440-450.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Iorio R. M., Bratt M. A. Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization. J Virol. 1984 Aug;51(2):445–451. doi: 10.1128/jvi.51.2.445-451.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Iorio R. M., Bratt M. A. Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin. Proc Natl Acad Sci U S A. 1985 Oct;82(20):7106–7110. doi: 10.1073/pnas.82.20.7106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Iorio R. M., Glickman R. L., Riel A. M., Sheehan J. P., Bratt M. A. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. Virus Res. 1989 Jul;13(3):245–261. doi: 10.1016/0168-1702(89)90019-1. [DOI] [PubMed] [Google Scholar]
  16. Iorio R. M., Syddall R. J., Glickman R. L., Riel A. M., Sheehan J. P., Bratt M. A. Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus. Virology. 1989 Nov;173(1):196–204. doi: 10.1016/0042-6822(89)90235-3. [DOI] [PubMed] [Google Scholar]
  17. Jorgensen E. D., Collins P. L., Lomedico P. T. Cloning and nucleotide sequence of Newcastle disease virus hemagglutinin-neuraminidase mRNA: identification of a putative sialic acid binding site. Virology. 1987 Jan;156(1):12–24. doi: 10.1016/0042-6822(87)90431-4. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. McGinnes L. W., Wilde A., Morrison T. G. Nucleotide sequence of the gene encoding the Newcastle disease virus hemagglutinin-neuraminidase protein and comparisons of paramyxovirus hemagglutinin-neuraminidase protein sequences. Virus Res. 1987 May;7(3):187–202. doi: 10.1016/0168-1702(87)90027-x. [DOI] [PubMed] [Google Scholar]
  21. Millar N. S., Chambers P., Emmerson P. T. Nucleotide sequence analysis of the haemagglutinin-neuraminidase gene of Newcastle disease virus. J Gen Virol. 1986 Sep;67(Pt 9):1917–1927. doi: 10.1099/0022-1317-67-9-1917. [DOI] [PubMed] [Google Scholar]
  22. Moore N. F., Burke D. C. Characterization of the structural proteins of different strains of Newcastle disease virus. J Gen Virol. 1974 Nov;25(2):275–289. doi: 10.1099/0022-1317-25-2-275. [DOI] [PubMed] [Google Scholar]
  23. Morrison T. G. Structure, function, and intracellular processing of paramyxovirus membrane proteins. Virus Res. 1988 May;10(2-3):113–135. doi: 10.1016/0168-1702(88)90010-x. [DOI] [PubMed] [Google Scholar]
  24. Nagai Y., Hamaguchi M., Maeno K., Iinuma M., Matsumoto T. Proteins of Newcastle disease virus. A comparison by partial protease digestion among the strains of different pathogenicity. Virology. 1980 Apr 30;102(2):463–467. doi: 10.1016/0042-6822(80)90115-4. [DOI] [PubMed] [Google Scholar]
  25. Nishikawa K., Morishima T., Toyoda T., Miyadai T., Yokochi T., Yoshida T., Nagai Y. Topological and operational delineation of antigenic sites on the HN glycoprotein of Newcastle disease virus and their structural requirements. J Virol. 1986 Dec;60(3):987–993. doi: 10.1128/jvi.60.3.987-993.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sakaguchi T., Toyoda T., Gotoh B., Inocencio N. M., Kuma K., Miyata T., Nagai Y. Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology. 1989 Apr;169(2):260–272. doi: 10.1016/0042-6822(89)90151-7. [DOI] [PubMed] [Google Scholar]
  27. Sato H., Hattori S., Ishida N., Imamura Y., Kawakita M. Nucleotide sequence of the hemagglutinin-neuraminidase gene of Newcastle disease virus avirulent strain D26: evidence for a longer coding region with a carboxyl terminal extension as compared to virulent strains. Virus Res. 1987 Sep;8(3):217–232. doi: 10.1016/0168-1702(87)90017-7. [DOI] [PubMed] [Google Scholar]
  28. Schaper U. M., Fuller F. J., Ward M. D., Mehrotra Y., Stone H. O., Stripp B. R., De Buysscher E. V. Nucleotide sequence of the envelope protein genes of a highly virulent, neurotropic strain of Newcastle disease virus. Virology. 1988 Jul;165(1):291–295. doi: 10.1016/0042-6822(88)90686-1. [DOI] [PubMed] [Google Scholar]
  29. Schuy W., Garten W., Linder D., Klenk H. D. The carboxyterminus of the hemagglutinin-neuraminidase of Newcastle disease virus is exposed at the surface of the viral envelope. Virus Res. 1984;1(5):415–426. doi: 10.1016/0168-1702(84)90027-3. [DOI] [PubMed] [Google Scholar]
  30. Sheehan J. P., Iorio R. M., Syddall R. J., Glickman R. L., Bratt M. A. Reducing agent-sensitive dimerization of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus correlates with the presence of cysteine at residue 123. Virology. 1987 Dec;161(2):603–606. doi: 10.1016/0042-6822(87)90158-9. [DOI] [PubMed] [Google Scholar]
  31. Smith G. W., Hightower L. E. Identification of the P proteins and other disulfide-linked and phosphorylated proteins of Newcastle disease virus. J Virol. 1981 Jan;37(1):256–267. doi: 10.1128/jvi.37.1.256-267.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Thompson S. D., Portner A. Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants. Virology. 1987 Sep;160(1):1–8. doi: 10.1016/0042-6822(87)90037-7. [DOI] [PubMed] [Google Scholar]
  33. Underwood P. A. Receptor binding characteristics of strains of the influenza Hong Kong subtype, using a periodate sensitivity test. Arch Virol. 1985;84(1-2):53–61. doi: 10.1007/BF01310553. [DOI] [PubMed] [Google Scholar]
  34. Underwood P. A., Skehel J. J., Wiley D. C. Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus. J Virol. 1987 Jan;61(1):206–208. doi: 10.1128/jvi.61.1.206-208.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Waxham M. N., Aronowski J., Server A. C., Wolinsky J. S., Smith J. A., Goodman H. M. Sequence determination of the mumps virus HN gene. Virology. 1988 Jun;164(2):318–325. doi: 10.1016/0042-6822(88)90544-2. [DOI] [PubMed] [Google Scholar]
  36. Weis W., Brown J. H., Cusack S., Paulson J. C., Skehel J. J., Wiley D. C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature. 1988 Jun 2;333(6172):426–431. doi: 10.1038/333426a0. [DOI] [PubMed] [Google Scholar]
  37. Weiss S. R., Bratt M. A. Polyadenylate sequences on Newcastle disease virus mRNA synthesized in vivo and in vitro. J Virol. 1974 Jun;13(6):1220–1230. doi: 10.1128/jvi.13.6.1220-1230.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yusoff K., Nesbit M., McCartney H., Emmerson P. T., Samson A. C. Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus. Virus Res. 1988 Nov;11(4):319–333. doi: 10.1016/0168-1702(88)90005-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. van Wyke Coelingh K. L., Winter C. C., Jorgensen E. D., Murphy B. R. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities. J Virol. 1987 May;61(5):1473–1477. doi: 10.1128/jvi.61.5.1473-1477.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES